Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.09.12
公司及全体董事、、、监事和高级管理人员对申请文件真实性、、、、准确性和完整性的承诺函
2017.09.12
关于公司股票价格波动不构成股价异动情况的说明
2017.09.12
北京市中伦律师事务所关于公司发行股份购买资产暨关联交易的法律意见书
2017.09.12
董事会关于重组履行法定程序的完备性、、、合规性及提交法律文件的有效性的说明
2017.09.12
董事会关于评估机构独立性、、、、评估假设前提合理性、、、、评估方法与评估目的的相关性及评估定价...
2017.09.12
关于召开2017年第四次临时股东大会的通知公告
2017.09.12
关于本次重组相关事项的承诺函
2017.09.12
发行股份购买资产暨关联交易报告书（草案）
2017.09.12
拟收购股权所涉及深圳市多普乐实业发展有限公司股东全部权益评估报告
2017.09.12
交易对方关于所提供信息真实性、、、准确性和完整性的声明和承诺函
第一页
上一页
73
74
75
76
77
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
